Press Release
Development of Novel Antibodies for Brain Disorders Based on Patient Big Data
2022.05.17
- - At BIO KOREA 2022, Nam-Gu Her, Head of the R&D Center at AimedBio, delivered a presentation titled "AimedBio's Patient-Centered AI Drug Discovery and Precision Medicine Technologies."
- - AimedBio develops promising therapeutic antibodies by leveraging patient-derived big data and patient-derived biological samples, enabling faster and more effective drug discovery.
Link: http://www.biospectator.com/view/news_view.php?varAtcId=1628